300 related articles for article (PubMed ID: 16635409)
1. Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats.
Zhang RY; Wang LF; Zhang L; Meng XN; Li SJ; Wang WR
Chin Med J (Engl); 2006 Apr; 119(8):649-55. PubMed ID: 16635409
[TBL] [Abstract][Full Text] [Related]
2. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
Zhang RY; Huang YL; Sun YH
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Jugdutt BI; Idikio H; Uwiera RR
Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
[TBL] [Abstract][Full Text] [Related]
6. Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.
Kim YK; Mankad S; Kim SJ; Takagi G; Tamura T; Gerdes AM; Bishop SP; Kramer CM
J Card Fail; 2003 Jun; 9(3):238-45. PubMed ID: 12815575
[TBL] [Abstract][Full Text] [Related]
7. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Izumi Y; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Cardiovasc Res; 2003 Jan; 57(1):48-54. PubMed ID: 12504813
[TBL] [Abstract][Full Text] [Related]
9. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
Wang L; Shi H; Huang JL; Xu S; Liu PP
Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
[TBL] [Abstract][Full Text] [Related]
10. Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-β/Smad signaling pathway.
He Y; Zhou X; Zheng X; Jiang X
J Cell Biochem; 2013 Jul; 114(7):1634-41. PubMed ID: 23355476
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats.
Zornoff LA; Paiva SA; Matsubara BB; Matsubara LS; Spadaro J
J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):203-9. PubMed ID: 11150409
[TBL] [Abstract][Full Text] [Related]
13. [Expression of connective tissue growth factor in cardiomyocyte of young rats with heart failure and benazepril intervention].
Zhang Q; Yi QJ; Qian YR; Li R; Deng B; Wang Q
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):733-7. PubMed ID: 17229371
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.
Yu CM; Tipoe GL; Wing-Hon Lai K; Lau CP
J Am Coll Cardiol; 2001 Oct; 38(4):1207-15. PubMed ID: 11583905
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
Ahmet I; Morrell C; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: a possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform.
Takahashi T; Anzai T; Yoshikawa T; Maekawa Y; Mahara K; Iwata M; Hammond HK; Ogawa S
J Am Coll Cardiol; 2004 Jan; 43(1):125-32. PubMed ID: 14715194
[TBL] [Abstract][Full Text] [Related]
17. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Kusuyama T; Yoshiyama M; Omura T; Nishiya D; Enomoto S; Matsumoto R; Izumi Y; Akioka K; Takeuchi K; Iwao H; Yoshikawa J
J Pharmacol Sci; 2005 Jul; 98(3):283-9. PubMed ID: 15997171
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
Lakhdar R; Al-Mallah MH; Lanfear DE
J Card Fail; 2008 Apr; 14(3):181-8. PubMed ID: 18381180
[TBL] [Abstract][Full Text] [Related]
20. Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?
Sugie T; Kagaya Y; Takeda M; Yahagi H; Takahashi C; Takahashi J; Ninomiya M; Watanabe J; Ichinohasama R; Tezuka F; Shirato K
Cardiovasc Res; 2003 Jun; 58(3):611-20. PubMed ID: 12798434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
